[Edaily Starin YUN GI BACK Reporter] The group THE BOYZ will continue their group activities as a 9-member lineup, excluding member New. While the members are pursuing individual activities through their respective agencies, they have agreed to continue group activities together, choosing a path of “separate yet together.” THE BOYZ members Sangyeon, Jacob, Younghoon, Hyunjae, Juyeon, Kevin, Q, Seonwoo, and Eric. THE BOYZ members Sangyeon, Jacob, Younghoon, Hyunjae, Ju-yeon, Kevin, Q, Seonwoo, and Eric announced on the 6th that they have recently finalized a group contract to resume activities as a full 9-member lineup. They are currently preparing for future group activities under a newly established label structure. This decision is intended as a message to their fans. Amid ongoing speculation regarding the direction of their activities, the members determined that securing the group’s future was the best way to honor their promise to fans. Moving forward, the members will sign individual contracts with agencies that allow them to leverage their respective strengths and continue their solo activities. At the same time, they plan to stably carry out THE BOYZ’s group activities through a separate collaborative framework. Their strategy is to maintain the group’s identity and continuity while managing solo and group activities separately. The members stated, “Our belief that all nine of us must stay together has never wavered from the very beginning,” adding, “Above all, we wanted to share this news first with THE B, who have been waiting for and worrying about THE BOYZ’s group activities.” They continued, “While doing our best in our respective roles, we will strive to continue the precious moments we’ve built with our fans as THE BOYZ,” adding, “We sincerely thank THE B for their unwavering love and support. We will prepare to repay you with our best performances.” Details regarding THE BOYZ’s future comeback and activity plans will be revealed in due course.
The slump in the non-investment-grade corporate bond market—which has been centered on BBB-rated bonds this year—is expected to spread to A-rated companies next year. As the burden of issuing corporat…
Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
A forecast indicates that U.S. production of humanoid robots will reach up to 400,000 units by 2030 and 1.5 million units by 2035. Analysts predict that as the humanoid robot industry moves beyond tec…